Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Virtual-reality education for patients undergoing transfemoral TAVI

Official title: VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease - A Randomized-Controlled Multicenter Study

Run by Heinrich-Heine University, Duesseldorf · NCT05552352 · Data updated 2026-11-12

This trial will see if virtual-reality patient education helps adults with severe aortic stenosis who are having elective transfemoral TAVI understand the procedure better and have fewer postprocedural complications.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorHeinrich-Heine University, Duesseldorf
Academic / other
Locations2 sites (Düsseldorf, North Rhine-Westphalia and 1 other locations)
StatusRecruiting
StartedOctober 5, 2022
Main results expectedAugust 31, 2026
Study endsFebruary 28, 2027
Registry record updatedAugust 28, 2025
Trial IDNCT05552352 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with high-grade aortic stenosis scheduled for elective transfemoral TAVI under conscious analgesia who can provide informed consent and use the VR equipment are ideal candidates.

Probably not a fit

Patients planned for general anesthesia, with severe hearing or vision impairment that prevents VR use, significant dementia, or insufficient language skills to follow the VR modules are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, randomized-controlled multicenter trial will randomize adults scheduled for elective transfemoral TAVI to receive virtual-reality (VR)–assisted education versus standard information. The VR program combines auditory, visual, written, and haptic modules to familiarize patients with the procedure, the care environment, and safety aspects. Investigators hypothesize that improved understanding and simulated orientation will reduce pre- and peri-procedural anxiety, disorientation, pain, and the risk of delirium, thereby lowering postprocedural complications. The primary outcome is expected to be length of hospital stay, with secondary outcomes including patient knowledge, anxiety scores, delirium incidence, and complication rates.

Why it matters

Potential benefit: If successful, patients could experience less anxiety and fewer complications after transfemoral TAVI, leading to shorter hospital stays.

How similar studies have gone: Other surgical and procedural settings have shown that VR education can reduce preprocedural anxiety and improve patient knowledge, but evidence specific to TAVI patients is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* High-grade aortic valve stenosis
* Indication for elective transfemoral transcatheter aortic valve implantation under analgesia (TAVI)
* Existing heart center decision
* Age ≥ 18 years
* Signed informed consent form

Exclusion Criteria:

* Surgery planned under general anesthesia
* Language barrier, defined as insufficient language proficiency at the discretion of the investigator to understand the purpose of the trial and follow the VR application.
* Severe hearing impairment, preventing the patient from understanding the sound of the VR goggles, tested with the VR goggles fitted without using the VRAP-Heart software
* Severe visual impairment that prevents viewing of the VR modules if it is not possible to use existing visual corrections (contact lenses, glasses) together with the VR glasses in the event of defective vision, tested with the VR goggles fitted without using the VRAP-Heart software
* Moderately severe or severe dementia syndrome noted in the medical history or identified during the informed consent discussion
* Known seizure disorder (epilepsy)
* Positive pregnancy test on inclusion and/or pregnancy is present
* Court ordered placement in an institution
* Any psychosocial condition that makes compliance with the protocol unlikely

Where it's running

  • Universitätsklinikum Düsseldorf, Klinik für Kardiologie, Pneumologie & Angiologie
    Düsseldorf, North Rhine-Westphalia, Germany
    Recruiting
  • Universitätsklinikum Köln, Klinik III für Innere Medizin, Herzzentrum, Kerpener Straße 62
    Cologne, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.